Skip to main content
    J

    Jade Biosciences, Inc. (JBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $15.40
    +0.07 (+0.42%)

    Market Cap: $1.06B

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Jade Biosciences, Inc. (JBIO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Jade Biosciences (JBIO) has a market cap of $1.06B and an enterprise value of $980.63M. Its share count is up 81.27% from a year earlier.

    Total Valuation

    Enterprise value is 7.58% below the market cap, as cash exceeds debt.

    Market Cap$1.06B
    Enterprise Value$980.63M
    Latest price (Nov 17, 2026)$15.40

    Key Dates

    The next earnings report is expected on Mar 4, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 4, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 17.54% in the quarter ended Sep 30, 2026.

    Shares Outstanding71.78M
    Shares Change (YoY)+81.27%
    Shares Change (QoQ)+17.54%

    Price Statistics

    The stock is up 43.93% over 52 weeks and trades 1.65% above its 50-day average.

    Beta (1Y)1.35
    52-Week Change+43.93%
    1-Month Change+11.35%
    3-Month Change-31.71%
    6-Month Change-29.62%
    5-Year Change-97.48%
    Total Return (1Y)+43.93%
    Total Return (3Y CAGR)-66.50%
    Total Return (5Y CAGR)-47.83%
    Return vs SPY (1Y)+10.18%
    Max Drawdown (1Y)-50.06%
    Max Drawdown (3Y)-99.22%
    Sharpe Ratio (1Y)0.29
    Correlation with SPY (1Y)0.27
    50-Day Average$15.15
    200-Day Average$18.22
    52-Week Range$11.02 to $28.00
    RSI (14 Days)51.5
    Average Volume (20 Days)885.35K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 16.03x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio16.03x
    Quick Ratio16.03x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -43.64% and return on assets is -40.87% over the last 12 months.

    Return on Equity (ROE)-43.64%
    Return on Assets (ROA)-40.87%
    Return on Capital Employed (ROCE)-43.20%
    ROA (5Y Average)-56.12%
    ROIC (5Y Average)-40.64%

    Scores

    JBIO has a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$9.00K
    Operating Income-$196.98M
    Pretax Income-$198.74M
    Net Income-$198.77M
    EBIT-$197.04M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 93.65% of the $486.39M in total assets.

    Cash and Equivalents$80.39M
    Total Debt$0
    Net Cash$80.39M
    Net Cash Per Share$1.12
    Working Capital$455.27M
    Shareholder Equity$455.50M
    Book Value Per Share$6.35
    Total Assets$486.39M
    Total Liabilities$30.89M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$130.30M
    FCF Per Share-$2.05
    Depreciation and Amortization$1.98M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    JBIO does not pay a dividend.

    Buyback Yield-4.02%
    Shareholder Yield-4.02%

    Stock Splits

    The last split was a 1-for-35 reverse split on Apr 29, 2025.

    Last Split DateApr 29, 2025
    Split TypeReverse split
    Split Ratio1:35

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About JBIO

    What is JBIO's market cap?

    Jade Biosciences has a market cap of $1.06B. Its enterprise value, which adds debt and subtracts cash, is $980.63M.

    How many shares of JBIO are outstanding?

    Jade Biosciences has 71.78M shares outstanding. The count is up 81.27% from a year earlier.

    Does JBIO pay a dividend?

    No. Jade Biosciences does not pay a dividend.

    How much debt does JBIO have?

    Jade Biosciences has $0 of total debt and $80.39M of cash and equivalents, a net cash position of $80.39M.